✦ LIBER ✦

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

✍ Scribed by Craddock, C; Quek, L; Goardon, N; Freeman, S; Siddique, S; Raghavan, M; Aztberger, A; Schuh, A; Grimwade, D; Ivey, A; Virgo, P; Hills, R; McSkeane, T; Arrazi, J; Knapper, S; Brookes, C; Davies, B; Price, A; Wall, K; Griffiths, M; Cavenagh, J; Majeti, R; Weissman, I; Burnett, A; Vyas, P

Book ID: 118183731
Publisher: Nature Publishing Group
Year: 2012
Tongue: English
Weight: 539 KB
Volume: 27
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2012.312

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved outcome in adult acute myeloid

Improved outcome in adult acute myeloid leukemia is almost entirely restricted to young patients and associated with stem cell transplantation

✍ Anders Wahlin; Berit Markevärn; Irina Golovleva; Marie Nilsson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

Factors affecting outcome of allogeneic

Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy

✍ Medeot, Marta; Tiribelli, Mario; Patriarca, Francesca; Sperotto, Alessandra; Ger 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Invasive fungal infections in patients w

Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?

✍ Morena Caira; Corrado Girmenia; Rafaela Maria Fadda; Maria Enza Mitra; Marco Pic 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

High-dose busulfan, cyclophosphamide, an

High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia

✍ Farag, S S; Bolwell, B J; Elder, P J; Kalaycio, M; Lin, T; Pohlman, B; Penza, S; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 191 KB

Prophylactic use of zoledronic acid to p

Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation

✍ Siddhartha Ganguly; Clint L. Divine; Omar S. Aljitawi; Sunil Abhyankar; Joseph P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

Reduced intensity conditioning prior to

Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype

✍ Philipp G. Hemmati; Theis H. Terwey; Gero Massenkeil; Philipp le Coutre; Lam G. 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 243 KB